You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis C Genotype 4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Hepatitis C Virus Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

Completed
Has Results
  • HCV
  • +2 more
  • (no location specified)
Jul 28, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
Has Results
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-450/r/ABT-267, ABT-333,

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Hepatitis C Trial (Grazoprevir, Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C
  • (no location specified)
Jan 15, 2021

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • San Diego, California
  • +24 more
Jul 14, 2021

Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (PR4 + LDV/SOF + ASV 4 wk, PR4 + LDV/SOF + SMV 4 wk, PR4 + LDV/SOF +

Recruiting
  • Chronic Hepatitis C Infection
  • PR4 + LDV/SOF + ASV 4 wk
  • +7 more
  • Beijing, Beijing, China
  • +1 more
Aug 27, 2021

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Different Antiviral Regimens for Hepatitis C Virus Relapse

Unknown status
  • Hepatitis C
  • +2 more
  • directly acting antivirals
  • Alexandria, Egypt
    Alexandria University.
Dec 4, 2020

Chronic Hepatitis C Infection Trial in Worldwide (Ombitasvir/paritaprevir/ritonavir, Dasabuvir, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • San Francisco, California
  • +20 more
Sep 7, 2021

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Hepatitis C, Chronic Trial in Riyadh (Elbasvir, Grazoprevir 50-100Mg Oral Tablet)

Completed
  • Hepatitis C, Chronic
  • Elbasvir, Grazoprevir 50-100Mg Oral Tablet
  • Riyadh, Saudi Arabia
    King Fahad Medical City
Nov 18, 2020

Hepatitis C Virus Infection, Response to Therapy of Trial in Cairo (Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER])

Withdrawn
  • Hepatitis C Virus Infection, Response to Therapy of
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Cairo, Almanial, Egypt
    Kasr Alainy Hospital
Apr 16, 2020

Chronic Hepatitis C Virus Infection Trial ((SOF and DCV), (SOF, DCV, and RBV))

Completed
  • Chronic Hepatitis C Virus Infection
  • (SOF and DCV)
  • (SOF, DCV, and RBV)
  • (no location specified)
May 13, 2020

Chronic Hepatitis C Virus Infection Trial (Sofosbuvir + Simeprevir + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • Sofosbuvir + Simeprevir + Ribavirin
  • (no location specified)
May 9, 2020

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

    Recruiting
    • Hepatitis C, Chronic
    • P1101 + Ribavirin
    • Chiayi City, Taiwan
    • +7 more
    Jun 30, 2022

    Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

    Completed
    Has Results
    • Chronic Hepatitis C Virus
    • Hepatitis C Virus
    • (no location specified)
    Jul 14, 2021

    Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection
    • (no location specified)
    Jul 14, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • (no location specified)
    Jul 8, 2021